Side-by-side comparison of AI visibility scores, market position, and capabilities
Parent Unilever 2024: Turnover €60.8B (+1.9%) | Personal Care: €13.6B (+5.2% organic sales growth) | Dove: ~40% of Personal Care, high-single digit growth | Key launches: whole-body deodorant, serum shower collection | Op Profit +12.6% to €11.2B, margin +170bp to 18.4% | H1-Q3 2025: Beauty/Wellbeing +4.1%, Personal Care +5.1% | 2025 target: 3-5% organic sales growth
Dove is a personal care brand created by Unilever in 1957, originally launched with its breakthrough Beauty Bar — a soap formulated with one-quarter moisturizing cream that was gentler on skin than conventional soap. Headquartered within Unilever's global personal care division, Dove's core product philosophy has always centered on real skin science: formulations that cleanse without stripping natural moisture, backed by clinical testing and dermatologist validation. This functional differentiation, combined with decades of brand investment, has made Dove one of Unilever's largest and most recognized consumer brands globally.\n\nDove's product portfolio spans bar soaps, body washes, antiperspirants, deodorants, lotions, hair care, and facial skincare, sold across more than 150 countries. The brand launched its "Real Beauty" campaign in 2004 — one of the most studied marketing campaigns in advertising history — which positioned Dove as an advocate for authentic self-image rather than idealized beauty standards. This purpose-driven positioning created emotional brand equity that differentiated Dove in a crowded personal care market and set a template for purpose-led consumer brands. Dove contributes approximately 40% of Unilever's Personal Care division revenue.\n\nDove delivered high-single-digit revenue growth within Unilever's portfolio, contributing to the parent company's overall performance against a backdrop of consumer value-seeking and private label competition. Unilever's scale in manufacturing, procurement, and global retail distribution provides Dove with structural advantages in reaching consumers across both developed and emerging markets. As personal care consumers increasingly prioritize efficacy, skin health, and brand values alongside price, Dove's combination of science-backed formulations and authentic brand identity keeps it at the top of a highly competitive category.
New York electronic bond trading (NASDAQ: MKTX) $763M FY2024 revenue; Open Trading $2T+ liquidity, 40% US IG bond electronification, portfolio trading growth competing with Tradeweb and Bloomberg.
MarketAxess Holdings Inc. is a New York City-based electronic fixed income trading platform — publicly traded on the NASDAQ (NASDAQ: MKTX) as an S&P 500 Financials component — operating the leading electronic trading marketplace for US investment-grade corporate bonds, US high-yield bonds, emerging market bonds, municipal bonds, and US Treasury securities through approximately 850 employees globally. In fiscal year 2024, MarketAxess reported revenues of $763 million with record trading volumes in US investment-grade bonds and emerging market credit, as the multi-year electronification trend in bond markets continued to shift institutional fixed income trading from voice broker-dealer phone execution to electronic all-to-all trading on MarketAxess's Open Trading marketplace. CEO Chris Concannon (joined 2023, formerly Cboe Global Markets president) leads MarketAxess's strategy of expanding market share beyond the institutional investment-grade core into rate products (US Treasuries, agency securities), high-yield, and portfolio trading as fixed income electronification accelerates — currently approximately 40% of US investment-grade bonds trade electronically versus 15% in 2015. MarketAxess's Open Trading protocol (anonymous all-to-all price discovery between buy-side, sell-side, and market makers) generated over $2 trillion in liquidity provision in 2024, reducing transaction costs versus bilateral dealer quotes by an average of $0.28 per $100 face value.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.